Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 8 of 8 for “"4-hpr"”.

  1. Pharmacologic modulation of fenretinide metabolism and cytotoxic mechanisms of an active metabolite in human lymphoid malignancies

    Fenretinide (N-(4-hydroxyphenyl)retinamide; 4-HPR) is a synthetic retinoid that is reported to be cytotoxic to, or inhibit the growth of, tumor cell lines and/or xenografts of various cancer types at concentrations of 1 – 10 μM. 4-HPR has also been studied clinically in phase I, II, and III …

    ttu Repository record for Pharmacologic modulation of fenretinide metabolism and cytotoxic mechanisms of an active metabolite in human lymphoid malignancies (opens in a new tab)

  2. Fenretinide increases dihydroceramide and dihydrosphingolipids due to inhibition of dihydroceramide desaturase.

    N-(4-Hydroxyphenyl) retinamide (4-HPR) is a derivative of all-trans-retinoic acid that induces apoptosis in cancer cell lines and is being tested in clinical trials as a relatively non-toxic anti-cancer agent. 4-HPR induces de novo sphingolipid biosynthesis and production of ceramide has been …

    gatech Repository record for Fenretinide increases dihydroceramide and dihydrosphingolipids due to inhibition of dihydroceramide desaturase. (opens in a new tab)

  3. Fenretinide sensitizes multidrug-resistant human neuroblastoma cells to antibody-independent and ch14.18-mediated NK cell cytotoxicity

    … the need for improved therapy protocols. 4-HPR is a synthetic retinoid known to induce apoptosis in variety of cancer cells mainly via the accumulation of ceramides. 4-HPR is also known to induce the up regulation of death receptors resulting in an enhanced apoptosis via DR pathway. In our …

    fu-berlin Repository record for Fenretinide sensitizes multidrug-resistant human neuroblastoma cells to antibody-independent and ch14.18-mediated NK cell cytotoxicity (opens in a new tab)

  4. C22:0- and C24:0-dihydroceramides confer cytotoxicity in T-cell acute lymphoblastic leukemia cell lines

    … N-(4-hydroxyphenyl)-retinamide (fenretinide, 4-HPR) is an anti-cancer agent under clinical evaluation in a variety of cancers, including in pediatric acute lymphoblastic leukemia (ALL). We have previously reported that 4-HPR induces cell death in association with an increase of dihydroceramides …

    ttu Repository record for C22:0- and C24:0-dihydroceramides confer cytotoxicity in T-cell acute lymphoblastic leukemia cell lines (opens in a new tab)

  5. HORMONE INDUCIBLE MILK PROTEIN GENE EXPRESSION AND ITS RELEVANCE TO MAMMARY CARCINOGENESIS (ORGAN CULTURE, CHEMOPREVENTIVE AGENTS, CLONING)

    Selenium, 4-HPR and (beta)-carotene have a preventive influence during the transformation of mouse mammary epithelial cells induced by a variety of oncogenic chemicals. However, nothing is known about the effect of these agents on normal functional differentiation. Therefore, studies were done to …

    nebraska Repository record for HORMONE INDUCIBLE MILK PROTEIN GENE EXPRESSION AND ITS RELEVANCE TO MAMMARY CARCINOGENESIS (ORGAN CULTURE, CHEMOPREVENTIVE AGENTS, CLONING) (opens in a new tab)

  6. Combination Therapy For the Treatment of Human Malignant Neuroblastoma

    … retinoid N-(4-hydroxyphenyl) retinamide (4-HPR) and the flavonoid apigenin (APG) suppressed starvation-induced autophagy and triggered apoptosis. In our final combination strategy, we induced cellular differentiation in immature neuroblastoma cells by treating with a combination of 4-HPR and …

    south-carolina Repository record for Combination Therapy For the Treatment of Human Malignant Neuroblastoma (opens in a new tab)

  7. Substrate-Based Inhibitors of Peptidylglycine á-Amidating Monooxygenase (PAM) as Anti-Proliferative Drugs for Cancer

    C-Terminal glycine-extended prohormones are enzymatically converted to á-amidated peptides, by peptidylglycine á-amidating monooxygenase (PAM). PAM is a bifunctional enzyme with two catalytic domains: peptidylglycine á-hydroxylating monooxygenase (PHM) and peptidylglycine …

    usf Repository record for Substrate-Based Inhibitors of Peptidylglycine á-Amidating Monooxygenase (PAM) as Anti-Proliferative Drugs for Cancer (opens in a new tab)

  8. Η αντιδραστικότητα των αιμοπεταλίων στη σήψη

    … of sepsis. Increased platelet reactivity (HPR or HTPR), shows the activity of the P2Y₁₂ receptor, despite the concomitant inhibition of clopidogrel. These patients have an increased incidence of thrombotic /ischemic episodes, including stent thrombosis. On the other hand, recent data have …

    greece Repository record for Η αντιδραστικότητα των αιμοπεταλίων στη σήψη (opens in a new tab)